Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Magenta Therapeutics, Inc. MGTA

Set alert

Price alert · MGTA

All alert types
0.70 0.00 0.00%

At close · Sep 11

0.69 Day range 0.7589
0.321 52-week range 1.81
Open
0.7085
Prev close
0.6996
Mkt cap
42.44M
Vol
375.91K
Avg vol
247.98K
EPS
-1.15
P/E
-0.61
Div yield
0.00%
More statistics
Low
0.69
High
0.7589
Forward P/E
39.25
Beta
2.12
Short ratio
1.43
Inst. own
51.04%
Dividend
0.00
Ex-div date
Earnings
Nov 2, 2023
50-d avg
0.6954
200-d avg
0.8519
1y target
1.00

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for MGTA has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

0.71 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 0.0×
FY 2016: -33.0×FY 2017: -8.8×FY 2018: -0.1×FY 2019: -8.7×FY 2020: -5.5×FY 2021: -4.0×FY 2022: -0.0×FY 2024: -0.0×FY 2025: 0.0×
FY 2016 5y median -0.0× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2024: 0.4×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.0×
FY 2016: 34.5×FY 2017: 6.2×FY 2018: 0.0×FY 2019: 4.2×FY 2020: 2.6×FY 2021: 1.5×FY 2022: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/FCF 0.0×
FY 2016: -46.8×FY 2017: -12.8×FY 2018: -0.1×FY 2019: -9.9×FY 2020: -5.9×FY 2021: -4.3×FY 2022: -0.0×FY 2024: -0.0×FY 2025: 0.0×
FY 2016 5y median -0.0× FY 2025
EV/EBITDA -116×
FY 2016: -33.2×FY 2017: -7.4×FY 2018: 0.9×FY 2019: -6.4×FY 2020: -4.1×FY 2021: -1.7×FY 2022: 0.3×FY 2024: -45.1×FY 2025: -116×
FY 2016 5y median -4.1× FY 2025
EV/Sales -24.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2024: -3.0×FY 2025: -24.4×
FY 2016 5y median 0.0× FY 2025
FCF Yield 0.0%
FY 2016: -2.1%FY 2017: -7.8%FY 2018: -898.3%FY 2019: -10.1%FY 2020: -17.0%FY 2021: -23.3%FY 2022: -5460.8%FY 2024: -2864.2%FY 2025: 0.0%
FY 2016 5y median -23.3% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin -8739.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: -1633.7%FY 2025: -8739.3%
FY 2016 5y median 0.0% FY 2025
Net Margin -7973.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: -1362.8%FY 2025: -7973.3%
FY 2016 5y median 0.0% FY 2025
ROE -32.9%
FY 2016: -104.3%FY 2017: -70.5%FY 2018: -39.5%FY 2019: -48.7%FY 2020: -48.1%FY 2021: -38.0%FY 2022: -68.0%FY 2024: -24.1%FY 2025: -32.9%
FY 2016 5y median -38.0% FY 2025
ROIC -35.5%
FY 2016: -102.5%FY 2017: -71.0%FY 2018: -40.8%FY 2019: -50.4%FY 2020: -48.4%FY 2021: -38.4%FY 2022: -56.1%FY 2024: -28.6%FY 2025: -35.5%
FY 2016 5y median -38.4% FY 2025
ROA -30.6%
FY 2016: -83.2%FY 2017: -65.2%FY 2018: -36.6%FY 2019: -42.6%FY 2020: -42.8%FY 2021: -34.5%FY 2022: -49.1%FY 2024: -22.7%FY 2025: -30.6%
FY 2016 5y median -34.5% FY 2025

Growth (YoY)

Revenue -67.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: -67.3%
FY 2016 FY 2025
Operating Income -74.7%
FY 2016: 0.0%FY 2017: -285.5%FY 2018: -67.8%FY 2019: -38.4%FY 2020: 5.1%FY 2021: 5.1%FY 2022: -8.3%FY 2024: 0.0%FY 2025: -74.7%
FY 2016 FY 2025
EPS (diluted) 100.0%
FY 2016: 0.0%FY 2017: -275.0%FY 2018: -3501.2%FY 2019: 97.1%FY 2020: 18.3%FY 2021: 21.7%FY 2022: -1958.0%FY 2024: 0.0%FY 2025: 100.0%
FY 2016 FY 2025
Free Cash Flow -65.1%
FY 2016: 0.0%FY 2017: -266.9%FY 2018: -102.6%FY 2019: -21.4%FY 2020: -7.1%FY 2021: 5.6%FY 2022: -10.9%FY 2024: 0.0%FY 2025: -65.1%
FY 2016 FY 2025

Financial Health

Current Ratio 13.3×
FY 2016: 4.7×FY 2017: 12.7×FY 2018: 13.9×FY 2019: 10.6×FY 2020: 13.3×FY 2021: 16.3×FY 2022: 7.9×FY 2024: 15.2×FY 2025: 13.3×
FY 2016 5y median 13.3× FY 2025
Quick Ratio 13.3×
FY 2016: 4.7×FY 2017: 12.7×FY 2018: 13.9×FY 2019: 10.6×FY 2020: 13.3×FY 2021: 16.3×FY 2022: 7.9×FY 2024: 15.2×FY 2025: 13.3×
FY 2016 5y median 13.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -116×
FY 2016: 0.5×FY 2017: 1.5×FY 2018: 1.0×FY 2019: 0.8×FY 2020: 0.7×FY 2021: 1.8×FY 2022: 0.4×FY 2024: -51.7×FY 2025: -116×
FY 2016 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2016: -56.9×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 18.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31